GTBPVSVCIG• 12 Months (Normalized)
GTBP vs VCIG (GT Biopharma Inc. vs VCI Global Limited)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+832.98%
GT Biopharma Inc.
Normalized Baseline0.00%
VCIG Performance $1.64
-99.98%
VCI Global Limited
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+932.96 pts
GTBP outperforming by 932.96 percentage points
GTBPVCIG
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP VCIG
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | GTBP Price | GTBP Gain (%) | VCIG Price | VCIG Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +832.98% | $1.64 | -99.98% | +932.96% |
| Sep 21, 2026 | $7.18 | +843.50% | $1.58 | -99.98% | +943.48% |
| Sep 18, 2026 | $7.16 | +840.87% | $1.66 | -99.98% | +940.85% |
| Sep 17, 2026 | $7.49 | +884.23% | $1.77 | -99.97% | +984.20% |
| Sep 16, 2026 | $7.81 | +926.28% | $1.65 | -99.98% | +1026.26% |
| Sep 15, 2026 | $9.00 | +1082.65% | $1.66 | -99.98% | +1182.63% |
| Sep 14, 2026 | $11.63 | +1428.25% | $1.72 | -99.97% | +1528.22% |
| Sep 11, 2026 | $8.61 | +1031.41% | $1.82 | -99.97% | +1131.38% |
| Sep 10, 2026 | $6.18 | +712.09% | $1.81 | -99.97% | +812.06% |
| Sep 09, 2026 | $5.98 | +685.81% | $1.84 | -99.97% | +785.78% |
| Sep 08, 2026 | $- | $1.80 | -99.97% | - | |
| Sep 04, 2026 | $0.24 | -68.33% | $1.82 | -99.97% | +31.64% |
| Sep 03, 2026 | $0.25 | -66.89% | $1.86 | -99.97% | +33.08% |
| Sep 02, 2026 | $0.28 | -62.81% | $1.83 | -99.97% | +37.16% |
| Sep 01, 2026 | $0.29 | -62.02% | $1.86 | -99.97% | +37.95% |
Page 1 of 17